Deferred Tax Assets, Net of Valuation Allowance in USD of PROKIDNEY CORP. from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
PROKIDNEY CORP. quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q4 2022 to Q4 2024.
  • PROKIDNEY CORP. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $1,063,000, a 28.8% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

PROKIDNEY CORP. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,063,000 -$430,000 -29% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 $1,493,000 -$266,000 -15% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 $1,759,000 31 Dec 2022 10-K 22 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.